News
This was the stock's second consecutive day of losses.
Matt Miksic from Barclays lowered the price target on Becton, Dickinson, and Company (NYSE:BDX) from $261 to $241, while ...
2d
Barchart on MSNHow Is Becton, Dickinson and Company’s Performance Compared to Other Medical Instruments & Supplies Stocks?Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) is a global medical technology company that develops, ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Becton, Dickinson and Company (BDX) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. Skip to content Home ...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But ...
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
3d
Zacks.com on MSNHologic Navigates Breast Health Slump: Is the Growth Thesis Intact?HOLX weathers Breast Health softness with rising service revenues, the Endomag acquisition and new tech on the horizon.
**NM signifies a non meaningful value. A dash signifies the data is not available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results